Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 50 of 71 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/25/23
End: 01/31/24
Due: 01/31/25
Phase: N/A
Priority: Normal
Start: 01/01/23
End: 12/31/23
Due: 12/31/24
Comparison of the Effects of Dexmedetomidine and Lidocaine on Blood Pressure and Heart Rate Response
Phase: N/A
Priority: Normal
Start: 05/29/24
End: 08/14/24
Due: 08/14/25
Phase: N/A
Priority: Normal
Start: 07/01/23
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 12/09/20
End: 09/30/21
Due: 09/30/22
Phase: N/A
Priority: Normal
Start: 09/01/22
End: 02/28/23
Due: 02/28/24
Phase: N/A
Priority: Normal
Start: 06/30/13
End: 04/30/14
Due: 04/30/15
Phase: N/A
Priority: Normal
Start: 02/02/23
End: 05/01/23
Due: 05/01/24
Phase: N/A
Priority: Normal
Start: 05/01/25
End: 05/01/26
Due: 05/01/27
Phase: N/A
Priority: Normal
Start: 04/01/18
End: 08/15/18
Due: 08/15/19
Phase: N/A
Priority: Normal
Start: 01/01/24
End: 04/01/24
Due: 04/01/25
Phase: N/A
Priority: Normal
Start: 05/01/24
End: 03/01/25
Due: 03/01/26
Phase: N/A
Priority: Normal
Start: 03/01/23
End: 10/31/23
Due: 10/31/24
Phase: N/A
Priority: Normal
Start: 11/30/22
End: 01/22/23
Due: 01/22/24
Phase: N/A
Priority: Normal
Start: 10/01/21
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 12/04/23
End: 12/20/24
Due: 12/20/25
Recovery Times of Half Dose Sugammadex and Neostigmine for Rocuronium-induced Neuromuscular Blockade
Phase: N/A
Priority: Normal
Start: 11/05/24
End: 02/28/25
Due: 02/28/26
Phase: N/A
Priority: Normal
Start: 02/13/25
End: 04/10/25
Due: 04/10/26
Phase: N/A
Priority: Normal
Start: 09/15/24
End: 04/30/25
Due: 04/30/26
Phase: N/A
Priority: Normal
Start: 08/15/22
End: 12/01/25
Due: 12/01/26
Phase: N/A
Priority: Normal
Start: 04/16/21
End: 07/31/25
Due: 07/31/26
Phase: N/A
Priority: Normal
Start: 09/15/24
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 10/01/24
End: 03/01/25
Due: 03/01/26
Phase: N/A
Priority: Normal
Start: 04/26/21
End: 05/31/23
Due: 05/31/24
Phase: N/A
Priority: Normal
Start: 11/08/23
End: 01/15/24
Due: 01/15/25